The Midwest CEPAC will deliberate and vote on ICER’s report on treatments for hereditary transthyretin-related (hATTR) amyloidosis. This meeting is open to the public.
Sep 13 2018
9:00 am - 5:00 pm
AMYLOIDOSIS RESEARCH CONSORTIUM, INC. 320 Nevada Street, Suite 210 Newton, MA 02460 USA | 617-467-5170
ARC is a 501(c)(3) nonprofit organization